What is Directo?
Founded in 2018 and headquartered in Melbourne, Australia, Directo operates as a business-to-business e-commerce platform specifically designed for pharmacies. The company aims to streamline the procurement and distribution of pharmaceutical products by connecting suppliers and pharmacy retailers through its digital marketplace. This strategic positioning allows Directo to address inefficiencies in the traditional pharmaceutical supply chain, offering a more integrated and efficient solution for its B2B clientele.
How much funding has Directo raised?
Directo has raised a total of $4.3M across 2 funding rounds:
Angel/Seed
$2.3M
Share Placement
$2M
Angel/Seed (2022): $2.3M with participation from Investible
Share Placement (2024): $2M, investors not publicly disclosed
Key Investors in Directo
Investible
Investible is an early-stage venture capital firm that backs ambitious founders. Their involvement suggests a focus on supporting innovative startups with high growth potential.
What's next for Directo?
The recent major strategic investment signals a pivotal moment for Directo, likely enabling the company to accelerate its expansion plans, enhance its platform capabilities, and potentially broaden its market reach. This capital infusion is expected to fuel further development of its B2B e-commerce solutions for the pharmacy sector, reinforcing its competitive edge. The company's focus on enterprise-level funding suggests a move towards scaling operations and solidifying its market presence, positioning it for significant future growth.
See full Directo company page
